Home Tags NASDAQ:ADVM

Tag: NASDAQ:ADVM

Adverum Biotechnologies Inc (NASDAQ: ADVM) Completes Investigational New Drug Amendment for...

Matt Wade - 0

Adverum Biotechnologies Inc. (NASDAQ: ADVM) Receives Orphan Drug Designation For ADVM-062

Kate Hudson - 0

Adverum Biotechnologies Inc. (NASDAQ:ADVM) Announces Q3 2020 Results With FDA removing...

Gavins Felicity - 0

Adverum Biotechnologies Inc. (NASDAQ:ADVM) And Trillium Therapeutics Inc. (NASDAQ:TRIL) Make Leadership...

Kate Hudson - 0

Adverum Biotechnologies Inc. (NASDAQ:ADVM) Reports unprecedented Positive Data from Cohorts 1-4...

Matt Wade - 0
12Page 1 of 2

Recent Post

Pfizer’s (NYSE: PFE) Ponsegromab Shows Promise in Fighting Cancer Cachexia

Gavins Felicity - 0
Pfizer (NYSE: PFE) recently announced positive results from a midstage trial of their experimental drug, ponsegromab, designed to treat cancer cachexia, a...

Singular Genomics (OMIC) Receives Buyout Offer, Stock Soars

Instil Bio (TIL) Surges on Promising Cancer Therapy Licensing Deal

Summit Therapeutics Secures $235 Million in Funding from Leading Biotech Investors

Monopar Therapeutics’ (MNPR) MNPR-101-Zr Shows Promising Tumor Targeting in Early Clinical...

© BioPharma Journal 2020